Dextenza® (dexamethasone ophthalmic insert) – New drug approval
December 3, 2018 - Ocular Therapeutix announced the FDA approval of Dextenza (dexamethasone ophthalmic insert), for the treatment of ocular pain following ophthalmic surgery.
Download PDF
